Print Page

其 他 安 全 警 示

 
新加坡: 羟氯喹及氯喹可导致低血糖
 
在香港,共有三种注册的药剂制品含有羟氯喹及一种含有氯喹。全部产品属医生处方药物。至今,卫生署未接获本地与该等药物有关的不良反应报告。鉴于新加坡卫生科学局的公告,卫生署将发信通知医护专业人员有关的新安全资讯,并将于药剂业及毒药管理局注册委员会的会议上讨论有关事宜。

详情请浏览以下英文版网址: http://www.drugoffice.gov.hk/eps/news/../24226.html


2014年12月27日(星期六)
香港时间12时15分
 
Related Information:
The United Kingdom: Hydroxychloroquine and chloroquine: increased risk of cardio... 上载于 2022-02-16
Update to information on psychiatric disorders for chloroquine and hydroxychloro... 上载于 2020-11-30
European Union: Update to information on psychiatric disorders for chloroquine a... 上载于 2020-11-28
The United States: FDA cautions against use of hydroxychloroquine or chloroquine... 上载于 2020-06-16
Singapore: Use of hydroxychloroquine (Plaquenil®) in the context of COVID 19: Ri... 上载于 2020-06-03
European Union: COVID-19: reminder of the risks of chloroquine and hydroxychloro... 上载于 2020-05-30
Canada: Chloroquine and hydroxychloroquine can have serious side effects. These ... 上载于 2020-04-27
The United States: Coronavirus (COVID-19) Update: FDA Reiterates Importance of C... 上载于 2020-04-25
European Union: COVID-19: reminder of risk of serious side effects with chloroqu... 上载于 2020-04-24
新加坡卫生科学局: 羟氯喹及氯喹可导致低血糖(给医护专业人员的信,内容为英文) 上载于 2014-12-29
 
back